This information was published on 2021-01-21T00:22:46 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2120275 |
| (220) |
15 Sep 2020
|
| (300) |
EM, 20 Aug 2020, 018293944
|
| (500) |
It is a condition of registration that any use in respect of pharmaceuticals will be limited to such goods containing the substance designated by the International Non-Proprietary Name ODEVIXIBAT.
|
| (511) (510) |
Class 5
Pharmaceutical preparations; pharmaceutical product for the treatment of liver and gastrointestinal diseases and disorders |
| (540) |
|
| (550) | Figurative |
| (730) |
Albireo AB
|
| (750) |
WRAYS PTY LTD
|
Find out more about publications on the About page.